Full Text View
Tabular View
No Study Results Posted
Related Studies
Intravenous Immunoglobulins for Post-Polio Syndrome
This study has been completed.
Study NCT01537575   Information provided by Azienda Ospedaliera Universitaria Integrata Verona

First Received on February 17, 2012.   Last Updated on February 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post-polio Syndrome
Additional conditions recognized in this trial
Poliomyelitis
Postpoliomyelitis Syndrome
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Enterovirus Infections
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Myelitis
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Picornaviridae Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
intravenous immunoglobulins
Saline solution
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Azienda Ospedaliera Universitaria Integrata Verona


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services